Overview
Details
Chat
Abbott Laboratories (ABT.US) Q1 2022 Earnings Conference Call
Live streaming time: 20/04/2022 13:00
Abbott Laboratories is dedicated to discovering, developing, manufacturing, and selling a wide and diverse range of healthcare products. It operates through the following segments: Established Pharmaceuticals, Nutritionals, Diagnostics, and Medical Devices. The Established Pharmaceuticals segment refers to the international sales of a range of branded generic pharmaceutical products. The Nutritionals segment caters to global sales of adult and pediatric nutritional products. The Diagnostics segment is a sub-segment of the market for diagnostic systems and tests used in blood banks, hospitals, commercial laboratories and alternative healthcare testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, diabetes care products for diabetic patients, and neurostimulation devices for the treatment of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1900 and is headquartered in Abbott Park, Illinois.
Risk and Disclaimer Statement:
The content on this page reflects the personal opinion of the author and is intended solely as general information for your reference. It shall not be construed as advice or a basis for any specific investment, business, or commercial decisions. The views expressed in the content do not represent any position of LongPort or any investment recommendations or endorsements related to LongPort. LongPort does not make any guarantee or commitment to the truthfulness, accuracy, or originality of the content. Investors should analyze the risks related to the investment based on their own circumstances and seek advice from a professional investment advisor when necessary.